CD151 immunoreactivity at diagnosis predicts early biochemical failure and metastasis in prostate cancer

被引：0
|
作者：
Vasquez, Catalina [1 ]
Martinez, Carlos [1 ]
Chan, Susanne [2 ]
Chalasani, Venu [1 ]
Gomez-Lemus, Jose [2 ]
Williams, Andrew [1 ]
Chin, Joseph [3 ]
Zijlstra, Andries [4 ]
Lewis, John [1 ]
机构：
[1] Univ Western Ontario, Translat Prostate Canc Res Grp, London, ON, Canada
[2] Univ Western Ontario, Dept Pathol, Translat Prostate Canc Res Grp, London, ON, Canada
[3] Univ Western Ontario, Dept Oncol, London Hlth Sci Ctr, Translat Prostate Canc Res Grp, London, ON, Canada
[4] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-2260
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2260
引用
收藏
页数：1
相关论文
共 50 条
  • [41] CD151 expression is frequent but unrelated to clinical outcome in head and neck cancer
    Julie C. Nienstedt
    Alexander Gröbe
    Patrick Lebok
    Franziska Büscheck
    Till Clauditz
    Ronald Simon
    Asmus Heumann
    Guido Sauter
    Christoph Moebius
    Adrian Münscher
    Rainald Knecht
    Marco Blessmann
    Max Heiland
    Christina Pflug
    Clinical Oral Investigations, 2017, 21 : 1503 - 1508
  • [42] Integrin-independent support of cancer drug resistance by tetraspanin CD151
    Hwang, Soonyean
    Takimoto, Takayuki
    Hemler, Martin E.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2019, 76 (08) : 1595 - 1604
  • [43] Integrin-independent support of cancer drug resistance by tetraspanin CD151
    Soonyean Hwang
    Takayuki Takimoto
    Martin E. Hemler
    Cellular and Molecular Life Sciences, 2019, 76 : 1595 - 1604
  • [44] Tetraspanin CD151 expression associated with prognosis for patients with advanced gastric cancer
    Byung Woog Kang
    Dakeun Lee
    Ho Young Chung
    Jae Ho Han
    Young-Bae Kim
    Journal of Cancer Research and Clinical Oncology, 2013, 139 : 1835 - 1843
  • [45] Effect of hypoxia-regulated CD151 expression on cancer cell adhesion
    Chien, Chun-Wei
    Lee, Jenq-Chang
    Lin, Shih-Chieh
    Lin, Po-Wen
    Lai, Yen-Yu
    Tsai, Shaw-Jenq
    FASEB JOURNAL, 2008, 22
  • [46] Tetraspanin CD151 is a novel prognostic marker in poor outcome endometrial cancer
    M A Voss
    N Gordon
    S Maloney
    R Ganesan
    L Ludeman
    K McCarthy
    R Gornall
    G Schaller
    W Wei
    F Berditchevski
    S Sundar
    British Journal of Cancer, 2011, 104 : 1611 - 1618
  • [47] Tetraspanin CD151 is a novel prognostic marker in poor outcome endometrial cancer
    Voss, M. A.
    Gordon, N.
    Maloney, S.
    Ganesan, R.
    Ludeman, L.
    McCarthy, K.
    Gornall, R.
    Schaller, G.
    Wei, W.
    Berditchevski, F.
    Sundar, S.
    BRITISH JOURNAL OF CANCER, 2011, 104 (10) : 1611 - 1618
  • [48] CD151 expression is frequent but unrelated to clinical outcome in head and neck cancer
    Nienstedt, Julie C.
    Groebe, Alexander
    Lebok, Patrick
    Buescheck, Franziska
    Clauditz, Till
    Simon, Ronald
    Heumann, Asmus
    Sauter, Guido
    Moebius, Christoph
    Muenscher, Adrian
    Knecht, Rainald
    Blessmann, Marco
    Heiland, Max
    Pflug, Christina
    CLINICAL ORAL INVESTIGATIONS, 2017, 21 (05) : 1503 - 1508
  • [49] Tetraspanin CD151 expression associated with prognosis for patients with advanced gastric cancer
    Kang, Byung Woog
    Lee, Dakeun
    Chung, Ho Young
    Han, Jae Ho
    Kim, Young-Bae
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (11) : 1835 - 1843
  • [50] The phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer
    Abramowitz, Matthew C.
    Li, Tiaynu
    Buyyounouski, Mark K.
    Ross, Eric
    Uzzo, Robert G.
    Pollack, Alan
    Horwitz, Eric M.
    CANCER, 2008, 112 (01) : 55 - 60
12345